Guidance for industry : criteria for safety and efficacy evaluation of oxygen therapeutics as red blood cell substitutes.

Bibliographic Details
Corporate Author: Center for Biologics Evaluation and Research (U.S.)
Format: Government Document eBook
Language:English
Published: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2004]
Subjects:
Online Access:https://purl.fdlp.gov/GPO/LPS112940
Description
Item Description:Title from PDF title page (viewed on May 21, 2009).
"Draft guidance."
"October 2004".
Electronic resource.
Physical Description:i, 17 pages : digital, PDF file.
Format:Mode of access: Internet at the FDA CBER web site. Address as of 5/21/09: http://www.fda.gov/cber/gdlns/oxytherbld.pdf ; current access is available via PURL.